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Abstract
Pericytes are perivascular mural cells of brain capillaries that are positioned centrally within the 
neurovascular unit between endothelial cells, astrocytes and neurons. This unique position allows 
them to play a major role in regulating key neurovascular functions of the brain. The role of 
pericytes in the regulation of cerebral blood flow (CBF) and neurovascular coupling remains, 
however, debatable. Using loss-of-function pericyte-deficient mice, here we show that pericyte 
degeneration diminishes global and individual capillary CBF responses to neuronal stimulus 
resulting in neurovascular uncoupling, reduced oxygen supply to brain and metabolic stress. We 
show that these neurovascular deficits lead over time to impaired neuronal excitability and 
neurodegenerative changes. Thus, pericyte degeneration as seen in neurological disorders such as 
Alzheimer’s disease may contribute to neurovascular dysfunction and neurodegeneration 
associated with human disease.
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A properly functioning central nervous system requires regulation of cerebral blood flow 
(CBF) and oxygen supply to match neuronal functional activity, known as neurovascular 
coupling1–3. Neurovascular coupling is regulated by synchronous action of different cell 
types within the neurovascular unit including neurons, vascular smooth muscle cells, 
endothelium and astrocytes4,5. Pericytes, mural cells of the capillary vessel wall6, play a 
critical role in the stabilization of the capillary wall7–9, maintenance of the blood-brain 
barrier10–12 and have been implicated in the regulation of capillary diameter and CBF13–15. 
Recent studies have demonstrated pericyte contractility in perfused brain slices including 
contractile responses to different pharmacological vasoactive agents and 
electrophysiological stimulation13–15. Moreover, has also been shown that active neurons 
increase their energy supply by dilating nearby arterioles and capillaries, and that capillaries 
dilate ahead of arterioles in vivo in response to neuronal stimulus14,15. Neuronally evoked 
capillary dilation in vivo, but not arteriolar dilation, has recently been shown to depend on a 
rise in intracellular calcium [Ca2+]i in astrocytes15.
Some studies, however, dispute the proposed physiological role of pericytes in neurovascular 
coupling. One study showed pericyte contractility to vasoconstrictors in vivo, but suggested 
that pericytes play insignificant role in neurovascular coupling16. The other study using 
genetically encoded microvascular mural cell labeling, functional calcium imaging and 
optogenetic light-driven cell activation showed that spontaneous cardiac and respiratory-
driven cerebral vasomotion and calcium currents are detectable only in arterioles but not in 
capillaries, that smooth muscle cells but not pericytes constrict vessels after light 
stimulation, and that capillary dilation in response to neuronal stimuli is not substantial, thus 
concluding that pericytes do not contribute to regulation of CBF responses17.
Pericyte degeneration is found in multiple neurodegenerative disorders exhibiting early 
neurovascular dysfunction2,3,18 including mild dementia19, Alzheimer’s disease20–23, and 
amyotrophic lateral sclerosis24. Additionally, it has been shown that pericytes die after 
ischemic stroke and constrict capillary blood flow during the reperfusion phase of 
stroke14,25. Therefore, elucidating whether pericyte degeneration contributes to CBF 
dysregulation and neurovascular dysfunction, as seen in these neurological disorders, is 
extremely important. Moreover, blood oxygen level-dependent (BOLD) functional imaging 
signals that depend on neurovascular coupling are typically abnormal in early stage 
Alzheimer’s disease reflecting CBF dysregulation and aberrant hemodynamic responses, as 
shown by numerous studies26. Whether pericyte degeneration contributes to changes in 
BOLD signals in early Alzheimer’s remains, however, presently unknown.
To address whether pericyte degeneration affects neurovascular coupling, we studied 
hemodynamic responses in loss-of-function pericyte-deficient platelet-derived growth factor 
receptor-β (Pdgfrβ+/−) mice, which at a young age develop a moderate 25% loss of pericyte 
coverage of the brain capillary wall12. Given that the vast majority of cortical vasculature in 
mice is composed of capillaries27, we hypothesized that if pericytes contribute to 
neurovascular coupling then Pdgfrβ+/− mice12 will have reduced hemodynamic responses 
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and diminished oxygen supply after neuronal stimulation, which over time will compromise 
neuronal function leading to neurodegenerative changes.
RESULTS
Impaired global and individual capillary responses
First, we found that the global CBF response to a hind limb electrical stimulus determined 
by laser doppler flowmetry (LDF)28 in young 1–2 month old Pdgfrβ+/− mice compared to 
age-matched littermate Pdgfrβ+/+ controls was reduced by 30% (Fig. 1a, 95% confidence 
interval (CI) of the mean difference [lower bound, upper bound] [4.9, 54.9]; Cohen’s d (d) = 
1.15). Next, we used in vivo two-photon laser scanning microscopy (TPLSM) in Pdgfrβ+/− 
mutants and controls to examine responses of individual capillaries (< 6 µm in diameter) and 
arterioles (7–25 µm in diameter including both pre-capillary and small penetrating arterioles) 
to a shorter-lasting electrical hind limb stimulus in a well-defined S1 cortical region (Fig. 
1b) determined to be responsive by intrinsic optical signal (IOS) imaging. First, we applied a 
low-pass and notch filter to all individual time courses of capillary responses to minimize 
cardiac and respiratory vasomotion artifacts (Fig. 1c), and then captured the time courses of 
diameter increase in each capillary by fitting a sigmoid parametric function to the individual 
capillary data traces in each animal (Supplementary Fig. 1). We computed time to 50% peak 
capillary dilation by averaging responses within individual animals and comparing data 
across animals (Fig. 1d, Supplementary Fig. 1). We found that capillaries in Pdgfrβ+/− 
animals responded with a 6.5 s delay (95% CI [−8.6, −4.4], d = 2.69) in reaching 50% peak 
capillary dilation compared to Pdgfrβ+/+ age-matched littermate controls (Fig. 1d; see 
Methods for details of diameter measurements), whereas the time to 50% peak arteriolar 
dilation was not different between the two groups (Fig. 1e,f; 95% CI [−4.2, 2.5], d = 0.25). 
Consistent with previous reports14,15, we found that in control Pdgfrβ+/+ mice arterioles 
reached 50% peak dilation with a delay of 2 s in average compared to capillaries that dilated 
first (95% CI [−4.2, −0.1], d = 0.92). In contrast, vessel responses in Pdgfrβ+/− mutants had 
the opposite order of dilation with capillary diameter increases lagging behind arteriolar 
diameter increases by 3.5 s in average (95% CI [0.2, 6.8] d = 1.02).
Immunostaining analysis of CD13-positive pericytes in the stimulated cortical S1 area in a 
subset of control Pdgfrβ+/+ mice studied for capillary dilation indicated a 77% pericyte 
coverage of lectin-positive endothelial profiles (< 6 µm in diameter) (Supplementary Fig. 
2a–c), consistent with previous reports8,11,12. Young pericyte-deficient Pdgfrβ+/− mutants 
compared to age-matched littermate controls had approximately 29% reduction in pericyte 
coverage reflecting a 22% absolute loss of pericyte coverage (Supplementary Fig. 2a,b; 95% 
CI [17.7, 26.6], d = 7.16), as reported12. Consistent with a delay in capillary diameter 
increases (Fig. 1c,d), analysis of TPLSM capillary linescans29 (Fig. 1g) indicated 55% delay 
in stimulus-driven red blood cell (RBC) flow velocity increase in capillaries of Pdgfrβ+/− 
mice compared to Pdgfrβ+/+ controls (Fig. 1h–i; 95% CI [−104.9, −6.0], d = 1.08). 
Importantly, there was no difference in the basal arteriolar or capillary vessel diameter 
between Pdgfrβ+/− and Pdgfrβ+/+ animals (Supplementary Fig. 3a; arterioles – 95% CI 
[−3.8, 2.9], d = 0.12; capillaries – 95% CI [−0.5, 0.2], d = 0.47), indicating that anatomical 
changes in the vessel diameter prior to stimulation did not influence vessel responses. 
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Similarly, there were no baseline differences before stimulation between RBC flow velocity 
in arterioles or capillaries between Pdgfrβ+/− and Pdgfrβ+/+ animals (Supplementary Fig. 3b; 
arterioles – 95% CI [−1.2, 1.0], d = 0.13; capillaries – 95% CI [−0.2, 0.3], d = 0.14). The 
smooth muscle thickness in diving arterioles was also similar in Pdgfrβ+/+ and Pdgfrβ+/− 
mice as shown by smooth muscle cell actin staining (Supplementary Fig. 3c,d; 95% CI 
[−1.1,0.4], d = 0.64).
To assess whether loss of pericyte coverage was directly responsible for the loss of capillary 
dilation, we took advantage of the natural “mosaic” situation of the present murine model 
where some segments of the capillary bed lack pericytes while the others are covered by 
pericytes. We crossed Pdgfrβ+/− mice with NG2-dsRed mice (Pdgfrβ+/−; dsRed) to identify 
pericyte-covered capillaries. NG2-dsRed mice express dsRed in pericytes, smooth muscle 
cells, and oligodendrocyte progenitor cells14. These mice have been used previously to 
elucidate the role of capillary vasodilatation in vivo and to identify pericyte-covered 
microvessels14. We determined capillary responses in Pdgfrβ+/−;dsRed mice, and measured 
the diameter changes of capillaries where dsRed-labeled pericytes were present (either 
somata or processes; responses did not differ significantly at these locations) and where no 
pericyte coverage was visible. Upon stimulation, active dilation of capillaries lacking 
pericyte coverage was barely detectable after 3 s compared to those with pericyte coverage 
that showed significant dilation in response to a stimulus (Fig. 1j,k, Supplementary movies 1 
and 2; 95% CI [0.2, 2.1], d = 1.38). These data suggest that capillaries lacking pericyte 
coverage in pericyte-deficient mice do not actively relax to generate the capillary dilation in 
contrast to capillaries covered by pericytes, altogether indicating that the lack of pericyte 
coverage likely leads to neurovascular uncoupling.
To investigate further whether young 1–2 month old pericyte-deficient mice compared to 
controls develop a global deficit in neurovascular coupling, we studied changes in IOS 
acquired under 530 nm illumination. IOS at this wavelength has been demonstrated to reflect 
changes in hemodynamic responses30,31. As illustrated by representative IOS images and 
traces, pericyte-deficient mice compared to controls show reductions in the peak signal 
amplitude and time to peak stimulus response (Fig. 2a, b) with an average 36% decrease in 
the peak amplitude (Fig. 2c; 95% CI [2.6, 70.5], d = 1.25) and a 2 s delay in 50% time to 
peak (Fig. 2d; 95% CI [−2.8, 0.2], d = 1.04) confirming abnormal neurovascular coupling. 
Importantly, neuronal activity assessed by in vivo local field potential (LFP) recordings in 
somatosensory cortex of the same mice indicated no difference in the shape, amplitude or 
slope of the LFPs (Fig. 2e–h; amplitude – 95% CI [−0.1, 0.1], d = 0.04; slope – 95% CI 
[−0.2, 0.2,], d = 0.16) after hind limb stimulation, demonstrating that neuronal activity is 
unchanged in 1–2 month old Pdgfrβ+/− mice. These data provide evidence for impaired 
hemodynamic responses in pericyte-deficient mice at an early stage when neuronal 
excitability is still normal.
Normal arteriolar responses and endothelial-dependent vasodilaton
We next studied whether changes in the arteriolar responses and endothelial-dependent 
vasodilation can contribute to neurovascular uncoupling in young Pdgfrβ+/− mice. 
Consistent with a comparable time to 50% peak arteriolar dilation (Fig. 1f), the stimulus-
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driven RBC velocity increase in arterioles was also similar in 1–2 month old Pdgfrβ+/− and 
Pdgfrβ+/+ mice (Fig. 3a; 95% CI [−2.0, 4.1], d = 0.38). We then imaged Alexa 633-positive 
arterioles in the S1 cortical region using acute brain slices from Pdgfrβ+/+ and Pdgfrβ+/− 
mice (Fig. 3b–e). Arteriolar constriction in response to phenylephrine was unchanged in 
Pdgfrβ+/− arterioles compared to Pdgfrβ+/+ arterioles (Fig. 3c,d; 95% CI [−5.7, 14.7], d = 
0.71). Similarly, there was no difference in smooth muscle relaxation induced by adenosine, 
an endothelium-independent vasodilator that acts as a direct vascular smooth muscle cell 
relaxant32, in Pdgfrβ+/+ and Pdgfrβ+/− arterioles pre-constricted with phenylephrine (Fig. 
3c,e; 95% CI [−12.1, 17.2], d = 0.29). We then tested in vivo the effect of adenosine, and 
found no changes in CBF responses between Pdgfrβ+/− mice and littermate controls, as 
determined by LDF using methods as previously reported32 (Fig. 3f; 95% CI [−5.7, 11.7] d 
= 0.78). These data show that the smooth muscle cell function is unaffected in Pdgfrβ+/− 
mice and therefore does not contribute to neurovascular uncoupling.
We also studied the effects of endothelium-dependent vasodilators acetylcholine for 
receptor-mediated vasodilation and the calcium ionophore A23187, a compound that 
produces endothelium-dependent vasodilation through receptor-independent mechanisms32, 
and found no changes in CBF responses between Pdgfrβ+/− mice and Pdgfrβ+/+ littermates 
(Fig. 3g,h; acetylcholine – 95% CI [−18.9, 11.3], d = 0.57; A23187 – 95% CI [−6.9, 1.2], d 
= 1.61), suggesting that the endothelial signaling is still intact at early stages in Pdgfrβ+/− 
mice, and can thus provide retrograde propagation of dilatory signals through the 
endothelium18.
Since alterations in neurovascular coupling might result from a cascade of alterations 
between trophically interdependent cells within the neurovascular unit we have analyzed 
astrocyte coverage of microvessels, the number of astrocytes and microglia and total 
microvascular length in 1–2 month old Pdgfrβ+/− mice. Immunostaining for two astrocyte 
markers - aquaporin-4 and glial fibrillar acidic protein (GFAP) - indicated no detectable 
changes in astrocyte coverage of the microvessel walls (e.g., normal coverage by 
aquaporin-4-positive endfeet) and astrocyte numbers (GFAP-positive astrocytes) 
(Supplementary Fig. 4a,b,c; AQP4 – 95% CI [−44.5, 14.1], d = 0.15; GFAP – 95% CI 
[−10.6, 4.5], d = 0.60) consistent with a previous report showing no detectable changes in 
astrocytes in Pdgfrβ+/− mice at 6–8 months of age12. These data also suggest that the 
astrocyte-dependent component of CBF regulation is likely intact at early stages in 
Pdgfrβ+/− mice. Similarly, there was no change in microglia number as shown by microglia-
specific Iba1 immunostaining (Supplementary Figure 4a,d; 95% CI [−5.1, 4.1], d = 0.16). As 
reported, an increase in microglia is seen in Pdgfrβ+/− mice only at a very late stage at 14–16 
months of age, but not before12. Collectively, these studies suggest no detectable changes in 
endothelial, smooth muscle cell-dependent and astrocyte-dependent mechanisms of flow 
regulation in the present pericyte-deficient model.
3D reconstructions of the vasculature revealed 10–16% lower capillary density in layers I-VI 
of the somatosensory cortex that while did not reach significance suggested vascular 
capillary phenotype in Pdgfrβ+/− mice compared to Pdgfrβ+/+ controls (Supplementary 
Figure 4e,f; 95% CI [−6.2, 38.8], d = 1.25 for capillary density), as reported12. In contrast, 
no changes were found in larger cortical vessels including the arterioles (Supplementary 
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Figure 4e,f; 95% CI [−140.3, 152.5], d = 0.07). To determine whether moderate 
microvascular reductions affect hemodynamic responses independently of pericyte coverage, 
we utilized another transgenic murine model with microvascular reductions but normal 
pericyte coverage, i.e., haploinsufficient mesenchyme homeobox 2 (Meox2+/−) mice33. 
Meox2+/− mice display approximately 30% reduction in the cortical capillary density due to 
primary endothelial hypoplasia, but have normal global CBF responses to neuronal 
stimulus12. We confirmed reduced capillary density and normal pericyte coverage in 
Meox2+/− mice (Supplementary Fig. 5a–c; capillary length – 95% CI [30.4, 39.8], d = 16.94; 
pericyte coverage – 95% CI [−11.6, 15.3], d = 0.20), and showed that these mice have 
normal stimulus-driven capillary and arteriolar responses as determined by TPLSM 
(Supplementary Fig. 5d–e; capillary – 95% CI [−1.8, 0.66], d = 0.91; arteriole – 95% CI 
[−2.8, 1.2], d = 0.70), consistent with previously reported normal global CBF responses12. 
Whether additional compensatory mechanisms can contribute to normal global 
hemodynamic responses in Meox2+/− mice despite reductions in capillary length12 remains 
unknown. However, the analysis of vessel responses in Pdgfrβ+/− and Meox2+/− mice 
suggests that a moderate reduction in capillary density alone does not lead to aberrant 
neurovascular coupling unless mice develop pericyte deficiency, as seen in Pdgfrβ+/− 
mutants.
Reduced tissue oxygenation and oxygen supply to brain under stimulus
Tight regulation of blood flow is critical for oxygen availability and normal brain 
function1,3,18. Therefore, changes in CBF responses due to pericyte degeneration could 
potentially create a state akin to chronic hypoperfusion or hypoxia12 around the capillary-fed 
tissue, which may then lead to metabolic stress and accelerated neuronal damage and loss. 
To assess tissue oxygenation, we used in vivo TPLSM pO2 (oxygen partial pressure) 
imaging in the cortex at two depths34 (Fig. 4a). Pdgfrβ+/− mice had an overall shift in tissue 
oxygenation to pO2 values lower than the typical 20–40 mmHg range observed in normal 
mice (Fig. 4b). At 200 µm from the brain surface (Fig. 4a), a significant portion of the tissue 
in Pdgfrβ+/− mice had low pO2 values (< 15 mmHg) compared to Pdgfrβ+/+ controls (Fig. 
4c: 100 µm – 95% CI [−7.7, −1.1], d = 3.01; 200 µm – 95% CI [−27.5, −10.0], d = 4.86). In 
particular, in tissue far from arterioles, Pdgfrβ+/− mice exhibited even lower pO2 (< 5 
mmHg), indicating potential existence of chronically hypoxic tissue pockets (Fig. 4a).
To study how the tissue oxygen supply changes in response to hind limb stimulus, we next 
conducted IOS measurements acquired at 627 nm in young Pdgfrβ+/− and Pdgfrβ+/+ mice. 
At this wavelength, light is dominantly absorbed by deoxy-hemoglobin and changes in IOS 
mainly reflect changes in oxygen consumption and/or delivery during hemodynamic 
response30,31. The initial dip (Fig. 4,d, e) is thought to be primarily the result of neuronal 
activity, i.e., increase in oxygen consumption increases deoxy-hemoglobin before a 
significant increase of CBF washes out deoxy-hemoglobin, but it is possible that it could 
also result from an initial increase in cerebral blood volume and total hemoglobin due to 
stimulus30,31. The positive peak (overshoot) (Fig. 4. d, e) is predominantly due to the deoxy-
hemoglobin washout31. Pdgfrβ+/− mutants compared to Pdgfrβ+/+ controls showed a 34% 
reduction in the IOS signal peak (overshoot) and a delay in time to peak (Fig. 4d,e,f; 95% CI 
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[15.8, 52.6], d = 2.92), indicating a reduction in oxygen delivery to the hind limb S1 cortex 
that supports the observed deficit in neurovascular coupling.
To corroborate these data, we studied reduced nicotinamide adenine dinucleotide (NADH) 
changes in response to hind limb stimulus. NADH is a molecule that is ubiquitously 
expressed and also intrinsically fluorescent in its reduced state, but not in its oxidized state 
(NAD+) allowing it to function as a cellular metabolic indicator35. Astrocytes labeled with 
SR101 were used to control for the possible effect of hemodynamic changes due to 
stimulation on NADH fluorescence intensity36 (Fig. 5a). TPLSM in vivo imaging of NADH 
revealed a significant transient NADH signal increase in Pdgfrβ+/− mice (compared to 
negligible change in Pdgfrβ+/+ controls) during functional activation (Fig. 5b; 95% CI [−0.1, 
0.0], d = 1.13), indicating a reduction in oxygen delivery compared to consumption. 
Together these data show that the capillaries in pericyte-deficient mice are incapable of 
supplying sufficient oxygen to brain either at rest or under stimulus.
We then sought to determine if the changes observed in CBF regulation and oxygen delivery 
compared to consumption paralleled changes in lactate metabolism. Lactate, produced by 
astrocytes, is considered an alternate fuel source for neurons, requiring less oxygen for 
energy production than glucose37,38. Using in vivo microdialysis of the somatosensory 
cortex, we found that 1–2 month old Pdgfrβ+/− mice exhibited a 47% higher interstitial fluid 
(ISF) level of lactate in the cortex than Pdgfrβ+/+ littermate controls (Fig. 5c; 95% CI [−8.1, 
102.7], d = 1.10), while the ISF glucose level (Fig. 5d; 95% CI [−65.9, 23.3], d = 0.66) and 
serum metabolite levels (Supplementary Fig. 6a,b: lactate – 95% CI [−24.1, 37.7] d = 0.32; 
glucose – 95% CI [−28.6, 30.7], d = 0.05) remained unchanged, likely reflecting a metabolic 
shift caused by insufficient oxygen supply. Moreover, upon neuronal stimulation via high [K
+] retrodialysis, we found a significantly lower increase in stimulus-driven lactate levels in 
the ISF in Pdgfrβ+/− mice compared to controls by 28% (Fig. 5e; 95% CI [5.2, 50.5], d = 
1.98), possibly reflecting increased utilization of lactate released from astrocytes by 
activated neurons in a setting of low oxygen when lactate becomes a preferred energy 
metabolite for neurons38.
Impaired neuronal function and secondary neurodegeneration
Finally, we studied whether pericyte reductions causing early hemodynamic changes can 
lead to impaired neuronal function over time. As shown above, 1–2 month old Pdgfrβ+/− 
mice develop significant hemodynamic changes due to pericyte dysfunction, but do not show 
changes in neuronal excitability (Fig. 2e–h). Using voltage-sensitive dye (VSD) imaging of 
evoked membrane potential responses in the hind limb S1 cortical area, we confirmed a 
normal depolarization pattern with no abnormalities in peak amplitude of response or 
response latency in 1–2 month old Pdgfrβ+/− mice (Supplementary Fig. 7a–d: time to peak – 
95% CI [−0.01, 0.05], d = 0.96 ; peak fluorescence change – 95% CI [−0.2, 0.2], d = 0.07). 
Structural analysis by dual labeling of neurons with NeuN (neuronal marker) and SMI-312-
positive neurofilaments revealed a normal number of neurons and normal neuritic density in 
the S1 cortical area (Fig. 6a–c; NeuN – 95% CI [−222.0, 306.4], d = 0.23; neuritic density – 
95% CI [−4.0, 5.4], d = 0.22) and hippocampus (not shown). Dual labeling for NeuN and 
terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) staining for DNA 
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fragmentation was negative (Fig 6a) demonstrating no detectable neuronal cell death at this 
early stage. Novel object recognition, nesting, and burrowing tests showed no behavioral 
deficits (Fig. 6d–f; NOR – 95% CI [−8.0, 22.7], d = 0.83; nest score – 95% CI [−0.4, 2.1], d 
= 1.55; food displaced – 95% CI [−80.7, 107.4], d = 0.18). However, 6–8 month-old 
Pdgfrβ+/− mice displayed abnormalities in the evoked cortical depolarization, peak 
amplitude of response and response latency (Fig. 6g–j; time to peak – 95% CI [−0.2, 0.0], d 
= 1.21; peak fluorescence – 95% CI [−0.0, 0.3], d = 1.38), had significantly reduced neuron 
numbers in the S1 cortex and CA1 hippocampal subfield by 15% and diminished neuritic 
density by 22%, respectively (Fig. 6k–m; NeuN cortex – 95% CI [−0.2, 30.4], d = 1.93; 
NeuN hippocampus – 95% CI [−1.8, 31.9], d = 1.24; SMI-312 cortex – 95% CI [2.2, 43.6], 
d = 1.43; SMI-312 hippocampus – 95% CI [2.9, 41.6], d = 1.48), and exhibited occasional 
double positive TUNEL/NeuN cells (Fig. 6k) and changes in behavior (Fig. 6n–p; NOR – 
95% CI [5.5, 30.8], d = 2.48; nest score – 95% CI [0.6, 1.4], d = 3.62; food displaced – 95% 
CI [15.4, 137.0], d = 2.76). Collectively these data suggest that pericyte-deficient mice 
develop age-related neurodegenerative changes as a continuum of the pathophysiological 
process initially triggered by pericyte degeneration.
As expected, global CBF responses to a stimulus progressively worsened in 6–8 month old, 
reduced by 58% relative to age matched controls (Supplementary Fig. 8a; 95% CI [49.7, 
66.1], d = 12.22), compared to a 30% reduction in 1–2 month old Pdgfrβ+/− mice (Fig. 1a), 
that could be attributed to both a progressive pericyte reduction at 6–8 months, i.e., 38% 
relative loss of coverage (Supplementary Fig. 8b,c; 95% CI [18.9, 56.8], d = 3.46) compared 
to 29% at 1–2 months (Supplementary Fig. 2a–b), and added secondary neuronal changes, 
as suggested by our data (Fig. 6g–m).
DISCUSSION
The present study shows that pericyte-deficient Pdgfrβ+/− mice develop early-reduced global 
and individual capillary CBF responses to neuronal stimulus resulting in neurovascular 
uncoupling, limited oxygen supply to brain and metabolic stress. At this early stage 
characterized by impaired hemodynamic responses, we did not find detectable changes in 
neuronal, endothelial, smooth muscle cell-dependent and astrocyte-dependent mechanisms 
of flow regulation suggesting that pericyte dysfunction is the primary factor driving CBF 
dysregulation in this loss-of-function model. We cannot rule out, however, a possibility that 
moderate reductions in capillary cortical density (10–15%), although found to be 
insignificant in the present study, can still contribute indirectly to diminished global CBF 
responses in young Pdgfrβ+/− mutants. On the other hand, our finding of delayed stimulus-
driven individual capillary responses would support direct causality between pericyte 
deficiency and diminished capillary dilation in this model. We also show that impaired 
hemodynamic responses lead over time to impaired neuronal excitability and secondary 
neurodegenerative changes. Thus, at a later stage, dysfunction in other neurovascular unit 
cell types including neurons may contribute indirectly to worsen abnormal hemodynamic 
responses initiated by pericyte degeneration.
It is conceivable that other vascular changes such as blood-brain barrier breakdown and 
accumulation of blood-derived toxic products in the brain10–12, may contribute to neuronal 
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dysfunction and neurodegenerative changes seen with age in pericyte-deficient mice. The 
exact contributions of impaired hemodynamic responses and blood-brain barrier breakdown 
to the pathophysiological process of neurodegeneration remain, however, presently 
unknown.
Although extremely useful for understanding pericyte biology and providing important 
insights into their role in regulating neurovascular functions7,9–12, the current models of 
PDGF-BB and PDGFRβ deficiency have their own limitations. For example, they cannot 
isolate the developmental impact of embryonic loss of PDGFRβ signaling on vascular 
phenotype in adult and aging brain. Additionally, smooth muscle cells also express 
PDGFRβ, which contributes to vascular phenotype in the embryonic central nervous system 
(CNS)7,9. On the other had, the role of pericytes and smooth muscle cells in adult brain 
could be different from their role in the embryonic CNS, as discussed9,12. The present study 
indicates, however, that smooth-muscle cell function and responses to vasodilators or 
constrictors are not altered in arterioles of young Pdgfrβ+/− mice. This is consistent with 
findings of intact stimulus-driven arteriolar diameter increases and normal RBC velocity 
arteriolar increase, and lack of basal differences in the arteriolar and capillary vessel 
diameter or basal RBC flow between young mutants and controls, as we report. Some 
studies have suggested that PDGFRβ is expressed even by neuronal progenitors in the 
subventricular zone39, which has not been confirmed by others in the embryonic CNS40 or 
adult brain12,41. Nevertheless, the present study examines CBF responses in the cortex but 
not subventricular zone containing the neuronal progenitor pool.
Recent studies in NG2-Cre transgenic mice expressing channelrhodopsin 2 (ChR2) found 
that light-driven optogenetic stimulation leads to constriction of smooth muscle cell-covered 
arterioles, but does not have a significant effect on pericyte-covered capillaries17. Because 
this study was focused on constrictive responses of mural cells17, it is difficult to make a 
direct comparison with the present findings focused on dilation of capillaries and arterioles 
in a loss-of-function model. Using an optogenetic stimulation causing a hyperpolarization of 
the mural cells followed by relaxation and dilation of the vessels would allow for more 
direct comparison with the present study. It has been suggested, however, that a controversy 
between the previous optogentic study in transgenic mice17 and recent findings by others 
demonstrating pericyte contractility and capillary dilation responses in normal mice in 
vivo14,15 might be attributed to a drift in pericyte definition, particularly renaming pericytes 
on precapillary arterioles42 to smooth muscle cells43.
Additionally, one wonders whether a threshold for optogenetic stimulation of ChR2 in 
smooth muscle cells and pericytes in vivo is comparable between these two cell types in 
NG2-Cre expressing ChR2 mice17. Smooth muscle cells and pericytes are known to express 
different types and amounts of contractile proteins and Ca2+ channels8,43,44 and therefore 
might have different thresholds for optogenetic stimulation. Interestingly, another recent 
optogenetic study focused in Pdgfrβ-Cre transgenic mice expressing ChR2 has shown that 
strong two-photon optogenetic stimulation of pericytes leads to their contractility 
constricting capillary lumens and reducing RBC flow in vivo (D.A. Hartmann, R.I. Grant 
and A.Y. Shih, Medical University of South Carolina, personal communication), opposite 
from the previous report in NG2-Cre expressing ChR2 mice17. Whether the differences in 
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optogenetic ChR2 stimulation of pericytes and contractility are model-dependent, 
optogenetic light stimulus source and duration-dependent, and whether different Cre-drivers 
can lead to differential ChR2 expression in different pericyte subpopulations, remains to be 
determined by future studies. However, our present data in control, non-transgenic mice 
corroborate recent findings by others by showing that upon longer-lasting electrical forepaw 
stimulation capillaries dilate ahead of arterioles in vivo15 consistent with the previous work 
showing that the same holds true after whisker stimulation14. These findings all together are 
consistent with several reports demonstrating Ca2+-dependent pericyte 
contractility13,14,45–48.
In contrast to all previous studies, the present study uses a loss-of-function approach to 
examine the effect of a loss of pericyte function on cerebrovascular regulation. We 
demonstrate that pericyte reductions lead to early hemodynamic cerebrovascular changes 
prior to changes in neuronal excitability and structure and/or changes in function of other 
neurovascular unit cell types, which links pericyte reductions to an age-dependent 
continuous pathophysiological process of neurodegeneration. Therefore, pericyte 
degeneration as seen in neurological disorders19–24 associated with neurovascular 
dysfunction, such as Alzheimer’s disease2,3,18, can contribute to impaired neurovascular 
coupling and diminished oxygen supply to brain, as shown by BOLD signal changes early in 
the disease26. These hemodynamic changes, in turn, may contribute to neurodegeneration 
accompanying human disease. Thus, pericytes could be an important new therapeutic target 
to treat neurovascular dysfunction and neurodegeneration.
Methods
Animals
Pdgfrβ+/− mice and their littermate controls on mixed 129S1/SvlmJ background were 
generated as we previously described9. All experiments were performed on 1–2 month old 
or 6–8 month old Pdgfrβ+/− mice and littermate Pdgfrβ+/+ controls unless otherwise 
specified. Pdgfrβ+/− mice with pericytes expressing dsRed (Pdgfrβ+/−;dsRed) were 
generated by crossing Pdgfrβ+/− mice with NG2-dsRed mice on C57Bl6 background11. 
Meox2+/− mice and their controls on C57Bl6 background were generated as we previously 
described28 were used at 1–2 mo of age. Both male and female animals were used 
throughout the experiments. Mice were housed in plastic cages on a 12 h light cycle with ad 
libitum access to water and a standard laboratory diet. During in vivo surgery and 
experiments, body temperature was maintained with electric heating pads with thermal 
feedback and respiration monitored. Intraperitoneal injections of 5% glucose in isotonic 
saline (0.2 mL/25 g) were administered every two hours. Most experiments were performed 
under isofluorane anesthesia (SomnoSuite, Kent Scientific), unless otherwise specified. For 
details see specific experiments below. All procedures were approved by the Institutional 
Animal Care and Use Committee at the University of Southern California with National 
Institutes of Health guidelines and the Massachusetts General Hospital Subcommittee on 
Research Animal Care.
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Animals were initially anesthetized with 100 mg/kg of ketamine and 50 mg/kg of xylazine, 
then fixed in a stereotaxic frame (Kopf Instruments) and transitioned to isoflurane 
anesthesia. A circular cranial window was drilled over the hind limb region of the 
somatosensory cortex (center at AP = −0.94 mm, L = 1.5 mm). The window was filled with 
2% low melt agarose (Sigma, A9539) in artificial cerebrospinal fluid (aCSF) and covered 
with a 3 mm round coverslip. Animals were maintained on isoflurane anesthesia for 
subsequent experiments.
Laser-doppler flowmetry (LDF)
CBF responses to hind-limb stimulation in anesthetized mice (~2% isofluorane) were 
determined using laser-Doppler flowmetry measured through a cranial window, as 
previously described23,49. The tip of the laser-Doppler probe (Transonic Systems Inc., 
Ithaca, NY) was stereotaxically placed 0.5 mm above the cranial window over the area 
determined to be responsive from IOS imaging (see below). CBF was recorded from the 
somatosensory cortex hind-limb region following electrical stimulation of the hind limb 
using a 60 s long stimulus. The percentage increase in CBF due to stimulation was obtained 
by subtracting the baseline CBF from the stable maximum plateau value reached during 
stimulus, and averaged over three trials per mouse.
For CBF response to drug application, the LDF probe was placed stereotaxically over the 
center of an open cranial window (center at AP = −0.94 mm, L = 1.5 mm). Drugs (10 µM 
Acetylcholine, 3 µM A23187, and 400 µM Adenosine, all from Sigma) were superfused 
individually over the window, and responses recorded as previously described27.
In Vivo Two-Photon Microscopy
Diameter and Velocity Measurements—To identify the brain region responsive to hind 
limb stimulation for two-photon microscopy diameter and velocity experiments, red (630 
nm) intrinsic optical signaling (IOS, see below) images were acquired in response to a 0.3 s 
electrical stimulus delivered to the contralateral hind limb at 5 V at a rate of 7 Hz, 5 ms 
pulse duration (6002 Stimulator, Harvard Apparatus) using custom electrical probes. At the 
frequency used, this is equivalent to a single 5 ms pulse stimulus. These images were not 
used for data analysis.
Areas determined to be responsive from IOS imaging to hind limb stimulation were located 
in the TPLSM and used for subsequent imaging. Mean arterial blood oxygen saturation 
(SpO2) and heart pulse rate were continuously monitored with a small-animal wrap 
transducer (TSD270B, Biopac Systems, Inc.) on the hind paw using an MP-150 Oxy200 
(Biopac Systems, Inc.). The following physiological parameters were maintained under 1.8–
2% isofluorane anesthesia: arterial SpO2 = 92 ± 3 mmHg and 75 ± 15 beats per minute. The 
vasculature was labeled via retro-orbital or tail vein injection of 70 kDa FITC-dextran (0.1 
mL of 10 mg/mL) and imaged through the cranial window. In vivo images and linescans 
were acquired at depths up to 400 µm below the pial surface using a custom-built Zeiss LSM 
5MP multiphoton microscope coupled to a mode locked Ti:sapphire laser (Mai Tai Deep 
See; Spectra Physics) set to 800 nm, or a Nikon A1R multiphoton microscope coupled to a 
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mode locked Ti:sapphire laser (Insight DS+; Spectra Physics) set to 820 nm for FITC 
excitation. FITC emission was collected using a 500–550 nm bandpass filter. Arteries were 
identified at the brain surface by morphology and direction of blood flow, and then followed 
into the brain for imaging.
An electrical stimulus (10 s, 10 Hz, 2 ms pulse duration) was delivered to the contralateral 
hind paw using custom electrical probes. Stimulus delivery and coordination with imaging 
were accomplished using a Digidata 1550 and accompanying pClamp software (Molecular 
Devices).
For diameter measurements, linescans were taken perpendicular to the vessels at 8.14–15 
Hz, generating an image of vessel diameter over time. Diameter line scans were analyzed as 
thresholded diameter vs. time images of each vessel with custom protocols written in Igor 
Pro 6 (WaveMetrics). First, images were smoothed with a 3×3 pixel Gaussian filter to 
remove noise, and thresholded using the Igor Pro built-in “fuzzy entropy” threshold routine 
to generate a black and white (binary) image of the vessel diameter vs. time. The Igor Pro 
custom analysis protocol identified the transitions between black/white and white/black in 
each line of the image, indicating the edges of the vessel, and then calculated the width of 
the vessel for each line in the image. The resulting diameter data was low-pass filtered (1 Hz 
cut off) and notch filtered (0.5 Hz), then smoothed with a 1 s window box filter. 
Subsequently, sigmoid parametric functions were then fit to the individual filtered vessel 
data traces to capture the overall time course of diameter increase and obtain the time to 
50% peak vessel dilation data. Vessels with basal diameters < 6 µm were considered 
capillaries and were confirmed by immunostaining (see below) for endothelial-specific 
Lycopersicon esculentum lectin fluorescent staining to visualize brain capillary profiles and 
pericyte-specific marker CD13 and vascular smooth muscle cell actin (SMα) to be CD13-
positive and SMα-negative. Vessels of basal diameter > 7 µm were considered arterioles 
(i.e., 7 – 25 µm basal diameter) and were confirmed by immunostaining (see below) to be 
SMα-positive and CD13-negative.
Vessels outside the 627 nm IOS response area were excluded from analysis. Vessels imaged 
within the 627 nm IOS response region (5–7 vessels, capillaries and arterioles, per animal on 
average) were analyzed. Based on the diameter analysis, any vessel that showed a focal drift 
occurring during the experiment, or if there were excessive breathing or movement artifacts 
were excluded. Only vessels with a diameter change larger than 1% after stimulus start were 
considered as responding vessels and taken for further analysis. Using these criteria, a total 
of 50–70% of vessels measured responded. Under these conditions, the average maximal 
diameter measured upon stimulus was approximately 2.5% above basal diameter.
For in vivo two-photon vessel diameter and velocity experiments, data from analyzed vessels 
were averaged together by mouse for statistical analysis.
For RBC velocity, linescans along the vessels were taken at a rate of 2.6 kHz24. Velocity 
data was analyzed using a MatLab algorithm as described24 then low-pass filtered (1 Hz cut 
off) and notch filtered (0.5 Hz), then box filtered with a 1 sec window to remove heartbeat 
and breathing artifacts using custom written protocols in Igor Pro to automate the filtering 
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process. As for diameter analysis, sigmoid parametric functions were then fit to the 
individual filtered vessel data traces to capture the overall time course of velocity increase 
and obtain the time to 50% peak RBC velocity data. Igor Pro code can be made available 
upon request.
For presentation in figure 1c,e,h the data was normalized such that the average basal 
diameter or velocity was set to zero, and the maximum set to 1. Basal diameters or velocities 
were taken as the average diameter of the vessel during the 10 sec prior to stimulus. For 
supplemental movies, high magnification 512×512 pixel images were taken at 1.57 s/frame 
in the FITC channel only, after identification of dsRed pericyte covered and uncovered 
capillary regions. Resulting image stacks were 3D gaussian filtered and registered 
(StackReg, ridged body algorithm) in FIJI (Image J). The final movies were rendered in 
Photoshop (Adobe) and FIJI.
For experiments with Pdgfrβ+/−; dsRed mice, the laser was set to 900 nm. FITC signal was 
collected as above, and the dsRed signal was collected using a 570–640 nm band pass filter 
(Chroma). An electrical hind limb stimulus was delivered as above (10 Hz, 10 s, 2 ms pulse 
width). Since the capillaries of Pdgfrβ+/− mice dilate slower than capillaries of control mice 
(Fig. 1d), we chose the timepoint of 3 s, prior to 50% diameter change occurrence in 
Pdgfrβ+/− mice to specifically examine the active dilation of pericyte-covered capillaries vs. 
pericyte-uncovered capillaries (Fig. 1k).
Tissue Oxygen partial pressure (pO2) measurements—Experiments were 
conducted as described previously29. Briefly, the 5–6 mo old Pdgfrβ+/− or Pdgfrβ+/+ mice 
were anesthetized with isoflurane, then the femoral artery was cannulated to administer the 
dyes, to continuously monitor the blood pressure and heart rate, and to sample systemic 
blood gases (pCO2 and pO2) and pH. A tracheotomy was performed, and a cranial window 
with dura removed was made. Blood pressure, heart rate, temperature, and end-tidal pCO2 
were monitored continuously during both surgery and experiment. Oxygen-sensitive dye 
(PtP-C343) was pressure-injected into cortical tissue using a glass micropipette inserted 
~400 µm below the cortical surface. The cranial window was then sealed with a glass 
coverslip and isoflurane was discontinued and replaced with alpha-chloralose. Mice were 
ventilated with a mixture of air and oxygen and the following physiological parameters were 
maintained: arterial pO2 = 115 ± 15 mmHg, arterial pCO2 = 37 ± 2 mmHg, mean arterial 
blood pressure = 100 ± 10 mmHg, and pH = 7.37 ± 0.02. A blood plasma was labeled by a 
small amount of FITC dye to obtain vascular images in the planes of pO2 measurement to 
coregister later with the 3D vascular stacks. Tissue pO2 was measured at 2 depths (100 µm 
and 200 µm from surface) at 800–1000 locations at each depth. At each pO2 imaging 
location, we excited phosphorescence by trains of femtosecond pulses from a Ti:sapphire 
oscillator at 840 nm, gated by an electro-optic modulator, and acquired decays by averaging 
multiple excitation cycles. Each cycle consisted of a 10-µs excitation gate, followed by a 290 
µs collection period. We averaged ~2,000 phosphorescence decays at each selected location 
for accurate pO2 determination, resulting in 0.6 s per single-point pO2 measurement. Blood 
plasma was subsequently labeled by Rhodamine dye to obtain vascular stack images.
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NADH Measurements—NADH is intrinsically florescent with two photon excitation, and 
provides an indication of local tissue metabolism30,31,50. The tissue was also stained with 
sulforhodamine 101 (SR101) dye (Invitrogen), which preferentially loads into astrocytes and 
oligodendrocytes and acts as a control marker to correct for fluorescence changes due to 
hemodynamic changes in response to stimulation31. For these experiments, the window area 
was topically loaded with SR101 dye for 15 minutes prior to NADH imaging. Imaging was 
performed under isoflurane anethesia (1.8–2%) using the two-photon microscope described 
above through a cranial window at a depth of 50 µm under the same stimulus used for vessel 
diameter and velocity measurements. The TPLSM excitation set to 740 nm. NADH 
fluorescence emission was collected at 435–485 nm, and SR101 fluorescence emission was 
collected at 650–710 nm. Interleaved NADH and SR101 images were taken at a rate of 6.12 
s/pair images at 50 µm depth. Images were loaded into Image J and ROIs were chosen so as 
to exclude the shadows of any large vessels. The SR101 signals were used to correct the 
average NADH ROI intensities for hemodynamic optical effects using a method reported 
previously31.
Two-Photon 3D Angiograpy
Mice were anesthetized with isofluorane, then injected with 100 µL of 1mg/ml Alexa Fluor 
594 lectin (Vector) into the femoral vein. After a 15 minute incubation, animals were 
transcardially perfused with 30 mL of PBS containing EDTA followed by 25 mL of 4% PFA 
in PBS at room temperature. The brain was removed, bisected down the midline, and 
cortices were separated from the rest of the brain. Cortices were placed between two 
microslides spaced 1.6 mm apart using metal washers and post-fixed in 4% PFA overnight. 
Cortices were then washed with 0.1 M PBS, and the somatosensory region extracted and 
embedded in a 4.5% agarose gel51. Brains were imaged at 1 µm steps using a 20x objective 
at 810 nm using a serial two-photon tomography microscopy as described51.
Using custom scripts and plugins by Tissue Vision, images were processed in MatLab and 
stitched using Image J51. Projection images were made using Imaris x64 v8 (Bitplane 
Scientific Software). Blood vessels were traced in 50 µm deep increments through the depth 
of the cortex using the Vida Suite software package written for MatLab52.
Voltage-sensitive dye (VSD) imaging
A cranial window was created over the hind-limb region in the somatosensory cortex. 
RH-1692 VSD (Optical Imaging) dissolved in aCSF was applied to the exposed cortex for 
90 min53. The brain was then washed with aCSF and sealed with low-melt agarose and a 
coverslip as above. Under isofluorane anesthesia (~1.5%), images were captured at 5 ms/
frame (184 × 124 resolution) using a 1/2 inch CCD MiCAM02-HR camera (SciMedia) 
coupled with MiCAM BV_ANA acquisition software. RH-1692 was excited using a 
MHAB-150W (Moritex Corp.) light source with a 632/22 filter, and fluorescence collected 
with a 665 nm long-pass filter. The contralateral hind-limb was stimulated by a brief 
mechanical vibration lasting 300 ms. Alternating image sets were taken with and without 
stimulus to generate “stimulus trial” and “baseline” responses. Next the baseline image set 
was subtracted from the stimulus trials to eliminate any background signal. 10 baseline 
subtracted trials were averaged to make up the final profile for each mouse. Time courses 
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were evaluated using a circular ROI centered over the hind-limb region as described 
previously54. Time courses were plotted using Igor Pro 6 and analyzed with Igor Pro 6 and 
Excel. Pseudocolor images for presentation were generated in Image J.
Intrinsic optical signal imaging (IOS)
IOS relies on changes in diffuse reflectance of the tissue due to changes in the tissue optical 
properties, notably changes in the blood volume and hemoglobin oxygen saturation55. 
Intrinsic optical signals were imaged through a cranial window. Under isofluorane 
anesthesia set at 1%, images were captured at 30 msec/frame using a 1/2 inch CCD 
MiCAM02-HR camera (SciMedia; 2x binned to 184 × 124 pixel resolution; 1 pixel = 16.5 
µm) with accompanying BV_ANA acquisition software.
IOS imaging at 530 nm illumination—At 530 nm the absorption extinction coefficient 
of oxy- and deoxy-hemoglobin are equal25,26. Therefore, at this wavelength, optical 
absorption of blood is dominated by the total hemoglobin concentration (HbT), independent 
of oxygen content, reflecting cerebral blood volume (CBV)26. These changes also reflect 
CBF changes as CBV and CBF changes are strongly coupled26. Images were captured under 
a 530 nm green LED light source, and collected through a 522/36 nm band pass filter 
(Chroma). To match two-photon diameter and velocity stimulus conditions, images were 
acquired in response to a 10 s electrical stimulus delivered to the contralateral hind limb at 5 
V at a rate of 10 Hz, 2 ms pulse duration (6002 Stimulator, Harvard Apparatus) using 
custom electrical probes. The resulting image sets were low pass filtered at 0.69 Hz, and the 
baselines corrected for any drift using the BV_ANA software. Signal time courses were 
evaluated using 13×13 pixel ROIs chosen in the region of peak signal change such that the 
regions did not include any large visible vessels, and were at least 30 µm away from any 
large vessels. Time courses were plotted using Igor Pro 6 and analyzed with Igor Pro 6 and 
Excel. Pseudocolor images for presentation were generated in Image J.
IOS imaging at 627 nm illumination—At 627 nm, optical absorption of blood is 
dominated by the deoxyhemoglobin (HbR) concentration 25,26,56. Images were captured 
under a 627 nm red LED light source, and collected through a 640/40 nm band pass filter 
(Chroma). The contralateral hind limb was stimulated by a brief mechanical vibration lasting 
300 ms. A total of 10 trials were performed and image data were averaged and stored for 
further quantification. To quantify the image results, customized Matlab scripts were used. A 
baseline frame was first obtained as the average of 10 frames (300 ms) before stimulation. 
For each 300 ms average frame (averaged from 10 frames) collected after stimulus onset, the 
intensity change was calculated relative to the baseline frame on a point-by-point basis. An 
adaptive 2D Wiener filter was applied to remove “salt & pepper” noise. Then, regions of 
interest (ROIs; 13×13 pixels) were chosen such that the regions did not include any large 
visible vessels, and were at least 30 µm from any large vessels, followed by quantification of 
the ROI intensity change over time.
In vivo electrophysiology
Following 530 nm IOS, electrophysiologic recordings were performed using custom-pulled 
borosilicate glass pipettes with filament (Sutter Instruments, outer diameter: 1.2 mm, inner 
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diameter: 0.69 mm) filled with sterile aCSF, attached to a CV-7B headstage (Axon 
Instruments), and mounted on a micromanipulator. The electrode was stereotaxically placed 
into Layer II (~200–300 µm deep) of the hindlimb somatosensory cortex at the peak 
responding location identified by 530 nm IOS. Data were acquired using a Multiclamp 700B 
amplifier and Digidata 1440A digitizer (Axon Instruments). Once the electrode was inserted, 
the depth was carefully adjusted so that the delivery of a single stimulus gave the maximal 
response. After recording a stable 10 second baseline, electrical hindlimb stimulus (10 Hz, 
10 s, 5 V, 0.1 ms pulse duration) was applied. Local field potentials (LFPs) were acquired 
using pCLAMP Clampex 10.6 (Molecular Devices), and were subsequently filtered offline 
(2 to 300 Hz) and analyzed using pCLAMP Clampfit 10.6 software. For each 10 s stimulus 
trial, the 100 LFPs generated per trial were averaged into a single trace, and the slope of the 
initial deflection and peak LFP amplitude were quantified per trace. We performed 5–6 trials 
(replicates) per animal and data were averaged per each animal from 5 Pdgfrβ+/+ mice (25 
experiments total, 2,500 LFPs) and from 6 Pdgfrβ+/− mice (36 experiments total, 3,600 
LFPs).
Immunohistochemistry
Mice were anesthetized with an i.p. injection of 100 mg/kg of ketamine and 50 mg/kg of 
xylazine, and transcardially perfused with 30 ml of phosphate buffer saline (PBS) containing 
EDTA followed by 30 ml of 4% PFA in PBS. Brains were removed and embedded into 
O.C.T. compound (Tissue-Tek) on dry ice, cryo-sectioned at a thickness of 18–20 µm. 
Sections were cut horizontally and those from depths of 50–150 µm, to coincide with 
TPLSM imaging depths, were used for analysis. Sections were subsequently blocked with 
5% normal donkey serum (Vector Laboratories) with Triton (0.05%) for 1 hour and 
incubated in goat anti-CD13 (1:200) primary antibody diluted in blocking solution overnight 
at 4° C. To visualize CD13-positive pericytes, Dylight-649-conjugated donkey anti-goat 
(1:100) secondary antibody was used for incubation 1 hour at room temperature. To 
visualize brain microvessels, sections were incubated with 488-conjugated lectin (Vector 
Laboratories FL-1171, 1:200). To visualize smooth muscle, sections were incubated with 
Cy3-conjugated anti-SM-α (1:100) antibody. NeuN, TUNEL, Iba1, Aquaporin-4, and GFAP 
staining and reagents were described previously (see Supplementary Table 1). Sections were 
cover slipped using fluorescent mounting medium (Dako) and scanned using a Zeiss 510 
meta confocal microscope with the following: 488 nm argon laser to excite Alexa Fluor 488, 
and emission collected through a 500–550 nm band pass (bp) filter; a 543 HeNe laser to 
excite Cy3, and emission collected through a 560–615 nm bp filter; a 633 HeNe laser to 
excite Dylight 649, and emission collected through a 650–700 nm bp filter. Z-stack 
projections and pseudo-coloring was performed using ZEN software (Carl Zeiss 
Microimaging).
Pericyte coverage analysis—Pericyte coverage analysis was performed as previously 
described9,57. Briefly, CD13 and lectin staining was performed in PFA fixed tissue sections 
as described above and signals from microvessels were separately subjected to automated 
threshold processing using Image J. The areas occupied by their respective signals were 
analyzed using the Image J Area measurement tool. Pericyte coverage was quantified as a 
percentage (%) of CD13-positive pericyte surface area covering lectin-positive capillary 
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surface area per field (420 × 420 µm). In each animal 5 randomly selected fields from the 
cortex were analyzed in 6 non-adjacent sections (~100 µm apart).
Smooth-muscle thickness analysis—SM-α staining was performed in PFA fixed 
tissue sections as described above and signals from axial diving arterioles were subjected to 
threshold processing. The thickness of the smooth muscle layer was determined by 
subtracting the diameter of the lumen from the diameter of the lumen and SM-α signal 
combined. This was done in 4 different angles for each vessel and the average of the 4 was 
used as the thickness for a given vessel.
Microvascular length measurements—In a few experiments the length of lectin-
positive capillary profiles was determined as we have previously reported9. Tissue sections 
were prepared and blocked as described above followed by incubation with Lycopersicon 
esculentum lectin (DL-1174, Dy Light 488, Vector Laboratories). The capillary profile 
length (vessels < 6 µm in diameter) was measured using the Image J “Neuro J” plug-in 
length analysis tool from 5 randomly selected fields in the hind limb S1 cortical area (420 × 
420 µm) per section from 6 non-adjacent (~100 µm apart) sections per animal, as we 
described9. The length was expressed in mm of lectin-positive vascular profiles per mm3 of 
brain tissue.
NeuN-Positive Neuronal Nuclei Counting—NeuN-positive neurons were quantified 
by using the Image J Cell Counter analysis tool. In each animal 6 randomly selected fields 
from the cortex were analyzed in 5 nonadjacent sections (~100 µm apart), as we reported9,54
SMI-312-Positive Neuritic Density—SMI-312 signals were subjected to threshold 
processing using Image J. The areas occupied by the signal were then analyzed by a blinded 
investigator using the Image J Area measurement tool. Total SMI-312-positive area was 
expressed as a percentage of total brain area in each field. In each animal 6 randomly 
selected fields from the cortex were analyzed in 5 nonadjacent sections (~100 µm apart), as 
we reported9,54.
Aquaporin-4-Positive Astrocyte End-Foot Coverage—Aquaporin-4 and lectin 
signals from microvessels < 6 µm in diameter were separately subjected to threshold 
processing. The areas occupied by their respective signals were analyzed using the Image J 
Area measurement tool. Total aquaporin-4-positive area was expressed as a percentage of 
total lectin-positive area in each field. In each animal 6 randomly selected fields from the 
cortex were analyzed in 5 nonadjacent sections (~100 µm apart), as we reported9.
GFAP-Positive Astrocyte Counting—GFAP-positive astrocytes were quantified by 
using the Image J Cell Counter analysis tool. In each animal 6 randomly selected fields (420 
× 420 µm) from the cortex were analyzed in 5 nonadjacent sections (~100 µm apart), as we 
reported9.
Microglia Quantification—The number of Iba1-positive microglia were counted using 
the Image J Cell Counter analysis tool. In each animal 6 randomly selected fields (420 × 420 
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µm) from the cortex were analyzed in 5 nonadjacent sections (~100 µm apart), as we 
reported9.
Ex Vivo Brain Slice Imaging
Brain slice preparation—Mice were intraorbitally injected with 50 µg Alexa 633 
hydrazide (Life Technologies) to identify arterioles58 and 50 µL Lycopersicon esculentum 
lectin (Vector Laboratories)9 to identify blood vessels at least 90 min and 30 min, 
respectively, prior to anesthesia (4% Isofluorane), rapid decapitation and slice preparation on 
a Leica VT1000S vibratome. Coronal cortical slices (350 µm) containing the hind limb area 
of the primary somatosensory cortex were cut in ice-cold high-sucrose, low-NaCl aCSF 
(85mM NaCl, 2.5 mM KCl, 4 mM MgSO4, 0.5 mM CaCl2, 1.25 mM NaH2PO4, 25 mM 
NaHCO3, 25 mM glucose, 74 mM sucrose, 0.5 mM ascorbate and 2 mM kynurenic acid) 
and stored in a submersion chamber containing normal aCSF (119 mM NaCl, 2.5 mM KCl, 
1.3 mM MgSO4, 2.5 mM CaCl2, 1 mM NaH2PO4, 26 mM NaHCO3, 11 mM glucose) with 2 
mM kynurenic acid, saturated with 95% O2:5% CO2, at room temperature. Experiments 
were performed in a submersion chamber perfused with aCSF and saturated with 95% 
O2:5% CO2.
Imaging of arterioles in live brain slices—Acute brain slices were transferred to a 
Zeiss Axio Examiner upright DIC fluorescence microscope equipped with a Hamamatsu 
Orca-Flash 4.0 camera, and images acquired using Zen Pro 2012 software (Carl Zeiss 
Microimaging). Slices were continually perfused with 95% O2:5% CO2 saturated aCSF 
heated to 37°C. After at least 10 min of acclamation in the recording chamber in aCSF, time 
lapse images of arterioles were acquired every 5 sec for 22 min (2 min of aCSF, 10 min of 
100 µM phenylephrine, 10 min of 400 µM adenosine). Vessel internal diameters were 
measured at several locations along the vessel using the line capillary tool and peak-to-peak 
measurement calculation function in ImagePro Premiere software (Media Cybernetics). 
Experiments and images where focal changes occurred were excluded from analysis. 
Constriction by phenylephrine values were calculated by comparing the vessel diameter of 
the last 3 min of phenylephrine application to aCSF baseline measurements. Relaxation by 
adenosine measurements were calculated by comparing the diameter of the last 3 min of 
adenosine to the last 3 min of phenylephrine application.
In vivo Microdialysis
In vivo microdialysis was performed to measure lactate and glucose levels in the ISF of 
isoflurane (~1%) anesthetized mice. An intracerebral guide cannula (Bioanalytical Systems, 
MBR-5) was stereotaxically implanted over the somatosensory cortex (coordinates: AP −0.5 
mm, L −1.5 mm, DV 0 mm) of the mouse. A 1 mm long microdialysis probe (Bioanalytical 
Systems, MBR 1–5), with 38 KDa molecular weight cutoff, extended from the tip of the 
cannula into the somatosensory cortex. Artificial cerebrospinal fluid (aCSF; Harvard 
Apparatus) was continuously perfused through the probe at a flow rate of 0.5 µL/min. After 
obtaining baseline values for three hours, high-[K+] (100 mM) aCSF was perfused into the 
cortex for 60 minutes via retrodialysis to induce local neuronal stimulation. The 
microdialysates, collected every 30 minutes, were then analyzed for lactate levels (Sigma).
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Novel object recognition (NOR), nesting, and burrowing tests were performed as previously 
described59.
Blood pressure measurements
Blood pressure (BP) measurements were performed using a non-invasive tail cuff method 
(CODA Monitor, Kent Scientific) on isofluorane anesthetized mice under the same 
conditions and stimulus used for the two-photon diameter and velocity measurements (see 
above) to confirm BP does not change under those experimental conditions. BP 
measurements were taken before, at the immediate conclusion of the stimulus, and for 
several subsequent post-stimulus time points. Mean BP was calculated using the formula: 
(2/3)Diastolic + (1/3)Systolic pressures. Mean blood pressure (MAP) was 83 ± 7 (mean ± 
s.e.m.) before stimulus for both 1–2 month old Pdgfrβ+/− and littermate control mice, and 83 
± 6 and 84 ± 7 for 1–2 month old Pdgfrβ+/− and littermate control mice, respectively, at the 
conclusion of stimulus.
Statistical analysis
All animals were randomized for their genotype information. Immunostaining experiments 
were blinded; the operators responsible for the experimental procedures and data analysis 
were blinded and unaware of group allocation throughout the experiments. Other 
experiments were analyzed, but not performed, in a blinded fashion. Sample sizes were 
calculated using nQUERY assuming a two-sided alpha-level of 0.05, 80% power, and 
homogenous variances for the two samples to be compared, with the means and common 
standard deviation for different parameters predicted from published data and our previous 
studies.
All data are expressed as mean ± 95% confidence interval, unless otherwise noted. Grubb’s 
outlier test was used to determine significant outliers, which were excluded from further data 
analysis (GraphPad). Lilliefors test was used to test normality of the data (XLSTAT). For 
parametric analysis, the F test was used to determine the equality of variances between the 
groups compared; statistical significance across two groups was tested by Student’s t-test 
(Microsoft Excel 2010). Mann–Whitney U test was used for non-parametric analysis (Prism, 
GraphPad). Bootstrapping (1,000 sampling size) was performed on data that could not be 
statistically distinguished from a non-normal distribution to calculate 95% confidence 
intervals (XLSTAT)60,61. Effect size (e.g. Cohen’s d) was calculated for all comparisons 
made (http://www.socscistatistics.com/effectsize/). The accepted level of statistical 
significance was p≤0.05.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Delayed capillary dilation and reduced capillary red blood cell flow in response to a 
hind limb stimulus in 1–2 month old pericyte-deficient Pdgfrβ+/− mice
(a) Cerebral blood flow (CBF) response to an electrical hind limb stimulus (60 s, 7 Hz, 2 ms 
pulse duration) determined by laser doppler flowmetry (LDF) as a percentage of baseline 
change in Pdgfrβ+/− mice (n=9) and age-matched Pdgfrβ+/+ (n=10) littermate controls. 
Circles denote individual values derived from 3 independent LDF measurements per mouse; 
mean ± 95% confidence interval (CI); t-test, equal variances: t = 2.52, p = 0.02. (b) 
Representative z-stack projection of capillary (C) and arteriole (A) diameter measurement 
locations by TPLSM (inset; yellow boxes). Scale bar = 20 µm. (c) Time courses of diameter 
changes (mean ± 95% CI) in capillaries in Pdgfrβ+/+ (red; n=12 mice; 37 total capillaries) 
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and Pdgfrβ+/− (blue; n=9 mice, 33 total capillaries) mice in the hind limb S1 cortical area 
after an electrical hind limb stimulus (10 s, 10 Hz, 2 ms pulse duration). Diameter changes 
are expressed relative to the respective basal capillary diameter prior to stimulation (value 
set as 0) and maximal diameter after stimulation (value set as 1). Vertical line denotes 
initiation of stimulus. Inset: sigmoid curve fits to the Pdgfrβ+/+ (red) and Pdgfrβ+/− (blue) 
time courses show average capillary diameter increase during the overall time course of 
dilation. (d) Average time (mean ± 95% CI) to 50% peak capillary diameter dilation increase 
in Pdgfrβ+/+ (red; n=12 mice; 37 total capillaries) and Pdgfrβ+/−(blue; n=9 mice; 33 total 
capillaries) mice from c (t-test, unequal variance: t = 6.48, p = 0.0002). Circles represent 
values per mouse derived from averaging individual capillary responses from sigmoid 
parametric fits to each capillary time course of dilation increase. (e) Time courses of 
diameter changes in arterioles in Pdgfrβ+/+ (red; n=8 mice; 18 total arterioles) and Pdgfrβ+/− 
(blue; n=11 mice; 20 total arterioles) mice in S1 cortex, in response to an electrical hind 
limb stimulus (10 s, 10 Hz, 2 ms pulse duration). Arteriolar diameter changes are expressed 
relative to the respective basal and maximal diameter prior to and after stimulation, 
respectively, as for capillaries in c. Vertical line denotes initiation of stimulus. Inset: sigmoid 
curve fits to the Pdgfrβ+/+ (red) and Pdgfrβ+/− (blue) average arteriole diameter increase 
during the overall time course of dilation increase. (f) Average time (mean ± 95% CI) to 
50% peak arteriole diameter dilation increase in Pdgfrβ+/− mice (blue; n=8 mice; 18 total 
arterioles) and Pdgfrβ+/+ mice (red; n=11 mice; 20 total arterioles) (t-test, equal variance: t = 
0.54, p = 0.60). Circles represent values per mouse derived from averaging the individual 
arteriolar responses. Time to 50% peak diameter increase was determined from individual 
sigmoid parametric fits to each arteriole time course of dilation increase. (g) Representative 
red blood cell (RBC) TPLSM capillary linescans from Pdgfrβ+/− and Pdgfrβ+/+ capillaries 
illustrating RBC velocity changes after an electrical hind limb stimulus (10 s, 10 Hz, 2 ms 
pulse duration). Dark lines closer to horizontal reflect faster RBCs. White lines: visual 
reference along RBC trajectories. Scale bar (left) = 0.35 s. (h) Time courses of stimulus-
driven RBC velocity changes in capillaries (mean ± 95% CI) from Pdgfrβ+/+ (red; n=12 
mice; 38 total capillaries) and Pdgfrβ+/− (blue; n=9 mice; 39 total capillaries) mice. RBC 
velocity changes are expressed relative to the respective basal RBC velocity prior to 
stimulation (value set as 0) and maximal velocity upon stimulation (value set as 1). Vertical 
line denotes initiation of stimulus. Inset: sigmoid curve fits to the Pdgfrβ+/+ (red) and 
Pdgfrβ+/− (blue) average capillary RBC velocity increase during the overall time course of 
velocity increase. (i) Average time (mean ± 95% CI) to 50% peak RBC capillary velocity 
increase in Pdgfrβ+/+ (red; n=12 mice; 38 total capillaries) and Pdgfrβ+/− (blue; n=9 mice; 
39 total capillaries) mice from h (t-test, equal variance: t = 2.35, p = 0.030). Circles 
represent values per mouse derived from averaging the individual RBC capillary velocity 
increase per mouse. Time to 50% peak RBC velocity increase was determined from sigmoid 
parametric fits of individual capillary time courses utilizing the overall time course of RBC 
velocity increase. (j) Representative measurement locations on capillaries either covered by 
a pericyte (P, red, top) or in the absence of a pericyte (NP, bottom) in Pdgfrβ+/− mice crossed 
with NG2-dsRed mice (Pdgfrβ+/−;dsRed). Scale bar = 10 µm. (k) Relative dilation of 
pericyte-present and pericyte-absent capillary segments after an electrical hind limb stimulus 
(10 s, 10 Hz, 2 ms pulse duration) in Pdgfrβ+/−;dsRed mice determined at 3 s after stimulus 
initiation. Responses (mean ± 95% CI) from 7 mice at 33 total pericyte-present (red) and 34 
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total pericyte-absent (blue) capillaries. Circles denote individual values per mouse derived 
from averaging all individual capillary dilation values per mouse per condition (t test, equal 
variance: t = 2.59, p = 0.02). P values by two-tail t-tests used as indicated for each dataset in 
the legend for panels a, d, f, i, and k.
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Figure 2. Impaired hemodynamic response in 1–2 month old pericyte-deficient Pdgfrβ+/− mice 
determined by intrinsic optical signal (IOS) imaging (530 nm) at a time-point when neuronal 
activity is unaffected as determined by local field potential (LFP) recordings
(a) Example grayscale images of the visualized somatosensory cortex showing vasculature 
(far left) and IOS signals under 530 nm illumination (pseudocolored) in response to an 
electrical hind limb stimulus (10 s, 10 Hz, 2 ms pulse duration) beginning at 0 s in Pdgfrβ+/− 
mice and Pdgfrβ+/+ littermate controls. Peak signals and peak signal times are indicated. 
Scale bar = 0.5 mm. Boxes indicate regions of interests (ROIs) at least 30 µm away from 
large surface blood vessels for data shown in panel b. (b) IOS signal time courses in 
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parenchymal regions for the examples shown in boxed ROIs in a. Arrows denote peak IOS 
signal times for Pdgfrβ+/− (red) and littermate control Pdgfrβ+/+ (blue) mice. Curves are 
averages of 10 trials for a representative individual mouse (mean ± 95% CI) per group. (c,d) 
Average (mean ± 95% CI) change in IOS peak height (t-test, equal variance, single tail: t = 
2.35, p = 0.02) (c), and time to 50% peak response signal (t-test, equal variance, single tail: t 
= 1.95, p = 0.04) (d) in 7 Pdgfrβ+/+ and 7 Pdgfrβ+/− mice in ROIs away from large surface 
vessels. Each circle represents the value per mouse averaged from 10 trials as shown in b. 
(e) Representative traces from single trials illustrating a train of evoked LFPs. After a 10 s 
baseline, hindlimb stimulus was applied (10 s, 10 Hz, 0.1 ms pulse duration) followed by a 
10 s run out in Pdgfrβ+/+ (top, red) and Pdgfrβ+/− (bottom, blue) mice. (f) 100 averaged LFP 
traces from a single trial (mean ± 95% CI) for Pdgfrβ+/+ (red) and Pdgfrβ+/− (blue) mice 
shown in e. Stimulus artifacts and LFPs are indicated in e and f. (g) Average (mean ± 95% 
CI) peak amplitude (t-test, equal variance: t = 0.07, p = 0.95) and (h) slope (t-test, unequal 
variance: t = 0.12, p = 0.80) from Pdgfrβ+/+ (n=5 mice; 2,500 total LFPs) and Pdgfrβ+/− 
(n=6 mice; 3,600 total LFPs) mice. Two-tail t-tests used unless otherwise indicated.
Kisler et al. Page 27













Figure 3. Arteriolar vasoactivity and endothelial-dependent vasodilation in 1–2 month old 
pericyte-deficient Pdgfrβ+/− mice and age-matched littermate controls
(a) Average time (mean ± 95% CI) to 50% peak arteriole RBC velocity increase in vivo 
from 10 Pdgfrβ+/− mice (24 total arterioles) and 7 Pdgfrβ+/+ mice (14 total arterioles) (t-test, 
equal variance: t = 0.74, p = 0.47) after an electrical hind limb stimulus (10 s, 10 Hz, 2 ms 
pulse duration) as in Fig. 1g–i. Circles denote individual values per mouse derived from 
averaging all times to 50% peak arteriolar RBC velocity increase per mouse. (b) 
Representative measurement of arteriole smooth muscle cell function in brain slices in the 
cortical S1 region in Pdgfrβ+/+ and Pdgfrβ+/− mice in resting conditions (aCSF, artificial 
cerebrospinal fluid), and after 100 µM phenylephrine (Phe; constriction) and 400 µM 
adenosine (relaxation). DIC: differential interference contrast bright field image. Alexa633: 
Arteriole-specific vessel marker confirming vessel type. (c) Average (mean ± 95% CI) 
arteriole diameter change relative to basal value in brain slices from 5 Pdgfrβ+/+ mice and 4 
Pdgfrβ+/− mice. (d-e) Quantification (mean ± 95% CI) of arteriole constriction by 
phenylephrine (t-test, equal variance: t = 1.05, p = 0.33) (d) and relaxation by adenosine (t-
test, equal variance: t = 0.41, p = 0.69) (e) in brain slices from 5 Pdgfrβ+/+ and 4 Pdgfrβ+/− 
mice: data from 2–3 slices were averaged per mouse. (f-h) In vivo cerebral blood flow 
(CBF) response to adenosine (400 µM; Mann-Whitney U test,, p=1.00) (f), acetylcholine (10 
µM; Mann-Whitney U test, p=1.00) (g) and A23187 (3 µM; Mann-Whitney U test, p=0.70) 
(h) determined by laser Doppler flowmetry in 3 Pdgfrβ+/+ and 3 Pdgfrβ+/− mice. Vasoactive 
agents were superfused over the exposed cortical surface. LDF measurements were 
performed in triplicate and an average individual value per animal was used for statistical 
analysis. Two-tail t-tests used unless otherwise indicated. Bootstrapped in panels f–h.
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Figure 4. Diminished brain tissue oxygen levels and oxygen delivery in young pericyte-deficient 
Pdgfrβ+/− mice
(a) Representative maximal intensity plots of rhodamine-labeld vasculature (left) and 
oxygen partial pressure (pO2) measurements for the same cortical regions at two different 
depths in 5–6 month old Pdgfrβ+/+ and Pdgfrβ+/− mice. Far right: Maximal intensity 
projection examples of the vasculature within the first 100 µm depth, and between 100–200 
µm depth. Scale bars = 100 µm. (b) Histograms of distribution of pO2 measurements at 100 
µm (left) and 200 µm (right) depth between 0 and 60 mm Hg. A total of 2076 measurements 
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at 100 µm and 2344 measurements at 200 µm for Pdgfrβ+/+ mice and a total of 2173 
measurements at 100 µm and 2867 measurements at 200 µm for Pdgfrβ+/− mice were pooled 
from 3 mice in each group. (c) Percent of image fields with pO2 values < 15 mmHg at 100 
µm (left) and 200 µm (right) depth (mean ± 95% CI) from 3 mice per group. Individual 
values were obtained from 381–1016 measurements per mouse per depth (Mann-Whitney 
U-test, single tail: p = 0.03 at 100 µm and p = 0.05 at 200 µm; bootstrapped at both depths). 
(d) Pseudocolored IOS image sequence illustrating the activity map in the S1 region in 
response to hind limb stimulation (300 ms mechanical vibration stimulus), showing baseline 
and peak responses of different phases including the initial dip (negative), followed by 
overshoot (positive peak), and undershoot (second negative deflection). Data were obtained 
using 627 nm illumination in 1–2 month old Pdgfrβ+/+ and Pdgfrβ+/− mice. Blues are 
negative signals and reds are positive signals. Scale bar = 0.5 mm. (e) Example IOS signal 
traces of intensity change in response to stimulus (at t = 0.0 s) from the ROIs (box locations, 
at least 30 µm away from large surface blood vessels) of images shown in d. Curves are 
averages of 10 trials for a representative individual mouse (mean ± 95% CI) per group. 
Arrows indicate the peaks of overshoot. (f) Quantification (mean ± 95% CI) of average peak 
intensity of the overshoot response (arrows in panel e) in 4 Pdgfrβ+/+ and 5 Pdgfrβ+/− mice 
(t-test, two-tail, equal variance: t = 4.39, p = 0.003).
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Figure 5. Metabolic changes in 1–2 month old pericyte-deficient Pdgfrβ+/− mice
(a) Representative images of NADH and SR101 measurements. Astrocyte somas appear as 
bright spots in the SR101 image. Scale bar = 20 µm. (b) Stimulus-induced SR101-corrected 
NADH signals (left), and average SR101-corrected NADH signal (right; mean ± 95% CI) in 
6 Pdgfrβ+/+ and 7 Pdgfrβ+/− mice (t-test, single tail, unequal variance: t = 1.81, p = 0.04) 
after an electrical hind limb stimulation (10 s, 10 Hz, 2 ms pulse duration) as in Fig. 1c–e. 
and Fig. 2a. (c-e) Microdialysis measurements (mean ± 95% CI) of cortical resting state 
interstitial fluid (ISF) lactate concentration in 6 Pdgfrβ+/+ and 5 Pdgfrβ+/− mice (t-test, 
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single tail, equal variance: t = 1.90, p = 0.04) (c), resting state ISF glucose concentration in 6 
Pdgfrβ+/+ and 5 Pdgfrβ+/− mice (t-test, equal variance: t = 1.08, p = 0.31) (d), and the 
percent change in stimulus-driven cortical ISF lactate concentration compared to the 
baseline levels in 5 Pdgfrβ+/+ mice and 4 Pdgfrβ+/− mice after potassium chloride 
retrodialysis (t-test, equal variance: t = 2.91, p = 0.02) (e). Two-tail t-tests used unless 
otherwise indicated.
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Figure 6. Cortical neuronal activity, neuronal number, neuritic density and behavior in 1–2 and 
6–8 month old pericyte-deficient Pdgfrβ+/− mice and age-matched littermate controls
(a) Double immunostaining for NeuN (neuronal marker) and SMI-312-positive 
neurofilament (top), and NeuN and TUNEL (bottom) in 1–2 month old Pdgfrβ+/+ and 
Pdgfrβ+/− mice. (b-c) Quantification (mean ± 95% CI) of NeuN-positive cells (t-test, equal 
variance: t = 0.37, p = 0.72) (b) and SMI-312-positive neuritic density (t-test, equal variance: 
t = 0.35, p = 0.73) (c) in the S1 cortex in 5 Pdgfrβ+/+ and 5 Pdgfrβ+/− mice at 1–2 months of 
age. In each animal 6 randomly selected fields from the cortex were analyzed in 5 
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nonadjacent sections (~100 µm apart) and data were averaged per mouse to obtain individual 
values (circles) as illustrated. (d-f) Novel object recognition (NOR) (d, n = 4 mice per 
group; t-test, equal variance: t = 1.17, p = 0.29), nest construction (e, n = 3 mice per group; 
Mann-Whitney U test, p = 1.00), and burrowing (f, food displacement; 7 Pdgfrβ+/+ and 6 
Pdgfrβ+/− mice; t-test, equal variance: t = 0.31, p = 0.76) in 1–2 month old mice; all values 
are mean ± 95% CI. (g) Representative pseudo-colored voltage-sensitive dye (VSD) image 
sequence of cortical neuronal activity in response to a 300 ms hind limb mechanical stimulus 
in 6–8 mo old Pdgfrβ+/+ and Pdgfrβ+/− mice. Hind limb (HL) region is indicated by dashed 
line. Scale bar = 0.5 mm. (h-j) Representative VSD intensity traces (h), time to peak (i, t-
test, single tail, equal variance: t = 1.91, p = 0.05) and peak fluorescence change (j; mean ± 
CI.; t-test, single tail, equal variance: t = 2.09, p = 0.04) in 5 Pdgfrβ+/+ and 4 Pdgfrβ+/− mice 
at 6–8 months of age. Arrows in (h) indicate peak VSD signal times for 6–8 month old 
Pdgfrβ+/− mice (blue) and Pdgfrβ+/+ (red) controls. Curves are averages of 10 trials for a 
representative individual mouse (mean ± 95% CI) per group. VSD data showing no changes 
in cortical neuronal activity in 1–2 month old Pdgfrβ+/− mice are shown in Supplementary 
Fig. 7. (k) Double immunostaining for NeuN (neuronal marker) and SMI-312-positive 
neurofilament (top), and NeuN and TUNEL (bottom) in S1 cortex in 6–8 month old mice. (l-
m) Quantification (mean ± 95% CI) of NeuN-positive cells (l, cortex: t-test, single tail, equal 
variance: t = 2.28, p = 0.03; hippocampus: t-test, equal variance: t = 2.05, p = 0.04) in 5 
Pdgfrβ+/+ and 5 Pdgfrβ+/− mice, and SMI-312-positive neuritic density (m, cortex: t-test, 
single tail, equal variance: t = 2.48, p = 0.02; hippocampus: t-test, single tail, equal variance: 
t = 2.56, p = 0.01) in the S1 cortex and CA1 hippocampus in 6 Pdgfrβ+/+ and 6 Pdgfrβ+/− 
mice at 6–8 months of age. In each animal 6 randomly selected fields from the cortex were 
analyzed in 5 nonadjacent sections (~100 µm apart) and data were averaged per mouse to 
obtain individual values (circles) as illustrated. (n-p) NOR (n, n = 4 mice per group; t-test, 
equal variance: t = 3.52, p = 0.01), nest construction (o, n = 5 mice per group; Mann-
Whitney U test, single tail, p = 0.05), and burrowing (p, food displacement; 7 Pdgfrβ+/+ and 
6 Pdgfrβ+/−; t-test, equal variance: t = 2.76, p = 0.02) in 6–8 month old mice. All values are 
mean ± 95% CI. Two-tail t-tests used unless otherwise indicated. Bootstrapped in panels e,o.
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